Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia

Neuroscience Letters

Volumn 216, Issue 1, 1996, Pages 1-4

  Rossi, Grace C ^a,b   Brown, George P ^a,b   Leventhal, Liza ^a,b   Yang, Ke ^a,b   Pasternak, Gavril W ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

6 Acetylmorphine; Eton itazine; Fentanyl; Heroin; Morphine 6 glucuronide

Indexed keywords

DIAMORPHINE; FENTANYL; OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CROSS TOLERANCE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030595288     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12976-1     Document Type: Article

References (20)

1. [1] Baron, A., Shuster, L., Elefterhiou, B.E. and Bailey, D.W., Opiate receptors in mice: genetic differences, Life Sei., 17 (1975) 633-640.
2. [2] Chien, C.-C., Brown, G., Pan, Y.-X. and Pasternak, G.W., Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor. Eur. J. Pharmacol., 253 (1994) R7-R8.
3. [3] Inturrisi, C.E., Schultz, M., Shin, S., Umans, J.G., Angel, L. and Simon, E.J., Evidence from opiate binding sites that heroin acts through its metabolites, Life Sci., 3 (1983) 773-776.
4. [4] Kolesnikov, Y.A., Pick, C.G., Ciszewska, G. and Pasternak, G.W., Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor, Proc. Natl. Acad. Sci. USA, 90 (1993) 5162-5166.
5. [5] Lange, D.G., Roerig, S.C. and Fujimoto, J.M., Absense of cross-tolerance to heroin in morphine-tolerant mice, Science, 206 (1980) 72-74.
6. [6] Martin, W. and Fraser, H., A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in post-addicts, J. Pharmacol. Exp. Ther., 133 (1961) 388-399.
7. [7] Oldendorf, W.H., Hyman, S., Braun, L. and Oldendorf, S.Z., Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection, Science, 178 (1972) 984-986.
8. [8] Pasternak, G.W., Pharmacological mechanisms of opioid analgesics, Clin. Neurophanmacol., 16 (1993) 1-18.
9. [9] Pasternak, G.W. and Standifer, K.M., Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology, Trends Pharmacol. Sci., 16 (1995) 344-350.
10. [10] Paul, D., Standifer, K.M., Inturrisi, C.E. and Pasternak, G.W., Pharmacological characterization of morphine-6β-gluruconide, a very potent morphine metabolite, J. Pharmacol. Exp. Ther., 251 (1989) 477-483.
11. [11] Pick, C.G., Nejat, R. and Pasternak, G.W., Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains, J. Pharmacol. Exp. Ther., 2265 (1993) 166-171.
12. [12] Rady, J.J., Roerig, S.C. and Fujimoto, J.M., Heroin acts on different opioid receptors than morphine in swiss-webster and ICR mice to produce antinociception, J. Pharmacol. Exp. Ther., 268 (1991) 448-457.
13. [13] Raffa, R.B., Martinez, R.P. and Connelly, C.D., G-protein antisense oligodeoxyribonucleotides and μ-opioid supraspinal antinociception, Eur. J. Pharmacol., 258 (1994) R5-R7.
14. [14] Reith, M.E.A., Sershen, H., Vadasz, C. and Lajtha, A., Strain differences in opiate receptors in mouse brain, Eur. J. Pharmacol., 74 (1981) 377-380.
15. [15] Rossi, G.C., Pan, Y.-X., Brown, G.P. and Pasternak, G.W., Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6β-glucuronide receptor, FEBS Lett., 369 (1995) 192-196.
16. [16] Rossi, G.C., Standifer, K.M. and Pasternak, G.W., Differential blockade of morphine and morphine-6β-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein α subunits in rats, Neurosci. Lett., 198 (1995) 99-102.
17. [17] Sanchez-Blazquez, P., Garcia-Espana, A. and Garzon, J., In vivo injection of antisense oligodeoxynucleotides to Gα subunits and supraspinal analgesia evoked by mu and delta opioid agonists, J. Pharmacol. Exp. Ther., 275 (1995) 1590-1596.
18. [18] Standifer, K.M., Chien, C.-C., Wahlestedt, C., Brown, G.P. and Pasternak, G.W., Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor, Neuron, 12 (1994) 805-810.
19. [19] Standifer, K.M., Jenab, S., Su, W., Chien, C.-C., Pan, Y.-X., Inturrisi, C.E. and Pasternak, G.W., Antisense oligodeoxynucleotides to the cloned δ receptor, DOR-1: uptake, stability and regulation of gene expression, J. Neurochem., 65 (1995) 1981-1987.
20. [20] Standifer, K.M., Rossi, G.C. and Pasternak, G.W., Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G-protein α subunits, Mol. Pharmacol., (1996) in press.